Allianz Asset Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Allianz Asset Management’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-20,000	Closed	-$185K	–	2553
2015 Q1	$185K	Hold	20,000	–	–	﹤0.01%	2203
2014 Q4	$185K	Hold	20,000	–	–	﹤0.01%	2199
2014 Q3	$179K	Hold	20,000	–	–	﹤0.01%	2175
2014 Q2	$157K	Hold	20,000	–	–	﹤0.01%	1825
2014 Q1	$158K	Buy	+20,000	New	+$161K	﹤0.01%	1803

Other funds holding CORV

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

AIS

AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return

Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Allianz Asset Management's CORV Position: Q2 2015 in Review

Allianz Asset Management sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2015, closing a stake of 20,000 shares — an estimated $185K sold.

Allianz Asset Management first reported a position in CORV in Q1 2014 and held it in 5 quarters. The position peaked at $185K in Q1 2015. 33 funds tracked by Wall St. Rank hold CORV as of Q2 2015.

Allianz Asset Management reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2015 after selling out during the quarter.
Allianz Asset Management sold 20,000 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2015, an estimated $185K.
Allianz Asset Management first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q1 2014 and held it in 5 quarters.
Allianz Asset Management's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $185K in Q1 2015.
33 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2015.

Based on Allianz Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.